近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.AntiretroviraltherapytopreventHIVtransmissioninserodiscordantcouplesinChina(2003-11):anationalobservationalcohortstudy.Lancet,2013Oct5;382(9899):1195-1203.observationalcohortstudy.JiaZ,MaoY,ZhangF,RuanY,MaY,LiJ,GuoW,LiuE,DouZ,ZhaoY,WangL,LiQ,XieP,TangH,HanJ,JinX,XuJ,XiongR,ZhaoD,LiP,WangX,WangL,QingQ,DingZ,ChenRY,LiuZ*,ShaoY*
2.Apeptide-basednanofibroushydrogelasapromisingDNAnanovectorforoptimizingtheefficacyofHIVvaccine.NanoLett.,2014Mar12;14(3):1439-1445.TianY,WangH,LiuY,MaoL,ChenW,ZhuZ,LiuW,ZhengW,ZhaoY,KongD,YangZ*,ZhangW,ShaoY*,JiangX*.
3.CorMut:anR/Bioconductorpackageforcomputingcorrelatedmutationsbasedonselectionpressure.BIOINFORMATICS,2014,30(14):2073–2075.ZhenpengLi,YangHuang,YaboOuyang,YangJiao,HuiXing,LingjieLiao,ShiboJiang,YimingShao*,LiyingMa*
4.TherapidlyexpandingCRF01_AEepidemicinChinaisdrivenbymultiplelineagesofHIV-1virusesintroducedinthe1990s.AIDS.2013Jul17;27(11):1793-802.FengY,HeX,HsiJH,LiF,LiX,WangQ,RuanY,XingH,LamTT,PybusOG,TakebeY,ShaoY*.
5.ImpactofHIVdrugresistanceonvirologicandimmunologicfailureandmortalityinacohortofpatientsonantiretroviraltherapyinChina.AIDS.2013Jul17;27(11):1815-1824.LiaoL,XingH,SuB,WangZ,RuanY,WangX,LiuZ,LuY,YangS,ZhaoQ,VermundSH,ChenRY,ShaoY*.
6.DeletionofC7LandK1LGenesLeadstoSignificantlyDecreasedVirulenceofRecombinantVacciniaVirusTianTan.PLoSOne.2013Jul1;8(7):e68115.LiuZ,WangS,ZhangQ,TianM,HouJ,WangR,LiuC,JiX,LiuY*,ShaoY*.
7.Genomicsequenceandvirulenceofclonalisolatesofvacciniavirustiantan,theChinesesmallpoxvaccinestrain.PLoSOne.2013Apr12;8(4):e60557.ZhangQ,TianM,FengY,ZhaoK,XuJ,LiuY*,ShaoY*
8.HIVdrugresistanceanditsimpactonantiretroviraltherapyinChineseHIV-infectedpatients.PLoSOne.2013;8(2):e54917.XingH,RuanY,LiJ,ShangH,ZhongP,WangX,LiaoL,LiH,ZhangM,XueY,WangZ,SuB,LiuW,DongY,MaY,LiH,QinG,ChenL,PanX,ChenX,PengG,FuJ,ChenRY,KangL,ShaoY*;ChineseNationalHIVDRSurveillanceandMonitoringNetwork.
9.AcomprehensivemappingofHIV-1genotypesinvariousriskgroupsandregionsacrossChinabasedonanationwidemolecularepidemiologicsurvey.PLoSOne.2012;7(10):e47289.HeX,XingH,RuanY,HongK,ChengC,HuY,XinR,WeiJ,FengY,HsiJH,TakebeY,ShaoY*;GroupforHIVMolecularEpidemiologicSurvey.
10.PreferentialCTLtargetingofGagisassociatedwithrelativeviralcontrolinlong-termsurvivingHIV-1infectedformerplasmadonorsfromChina.CellRes.2012May;22(5):903-14.JiaM,HongK,ChenJ,RuanY,WangZ,SuB,RenG,ZhangX,LiuZ,ZhaoQ,LiD,PengH,AltfeldM,WalkerBD,YuXG,ShaoY*
11.TracingtheoriginandhistoryofHIV-1subtypeB'epidemicbynearfull-lengthgenomeanalyses.AIDS.2012Apr24;26(7):877-84.LiZ,HeX,WangZ,XingH,LiF,YangY,WangQ,TakebeY,ShaoY*.
12.Profilesofneutralizingantibodyresponseinchronicallyhumanimmunodeficiencyvirustype1cladeB'-infectedformerplasmadonorsfromChinanaivetoantiretroviraltherapy.JGenVirol.2012Oct;93(Pt10):2267-78.HuX,HongK,ZhaoC,ZhengY,MaL,RuanY,GaoH,GreeneK,Sarzotti-KelsoeM,MontefioriDC,ShaoY*.
13.TheeffectsofHIVTatDNAonregulatingtheimmuneresponseofHIVDNAvaccineinmice.VirolJ.2013Sep30;10(1):297.LiuY,LiF,QiZ,HaoY,HongK,LiuY,CongY*,ShaoY*.
14.PhenotypicandGenotypicCharacterizationofHumanImmunodeficiencyVirusType1CRF07_BCstrainsCirculatingintheXinjiangProvinceofChina.Retrovirology.6:45,2009.LiyingMa,YanfangGuo,LinYuan,YangHuang,JianpingSun,ShuilingQu,XiaolingYu,ZhefengMeng,XiangHe,ShiboJiang,YimingShao*
15.Chapter19:TheHIVEpidemic:DevelopingCountries(fromHIV:FromBiologytoPreventionandTreatment).ColdSpringHarborLaboratoryPress,2011inUS.CarolynWilliamson*andYimingShao.